Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...
The Biden administration on Friday released the next round of prescription drugs selected for Medicare price negotiations, ...